SomaLogic, Inc. is a U.S.-based enterprise specializing in the identification of protein biomarkers and the development of clinical diagnostic solutions. A core aspect of its technology involves the creation of slow off-rate modified aptamers (SOMAmers) – unique nucleic acid-based reagents meticulously designed to specifically bind with their target proteins. The company also provides its proprietary SomaScan services, which enable the simultaneous detection and precise quantification of numerous proteins within intricate biological samples.
| Date | Est. | Actual | |
|---|---|---|---|
| Nov 8, 2023 | -$0.17 | -$0.12 | Beat |
| Aug 14, 2023 | -$0.18 | -$0.13 | Beat |
| May 11, 2023 | -$0.21 | -$0.18 | Beat |
| Mar 28, 2023 | -$0.26 | -$0.26 | Beat |
| Nov 14, 2022 | -$0.20 | -$0.18 | Beat |
| Aug 15, 2022 | -$0.19 | -$0.13 | Beat |